TBIO.jpg
Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
June 23, 2020 00:59 ET | Translate Bio, Inc.
-- The two companies will build upon their existing collaboration to pursue novel mRNA vaccines aimed at broadly addressing current and future infectious diseases -- -- Translate Bio to receive...
red.jpg
RedHill Biopharma to Provide Update on its COVID-19 and other Development Programs at MedInvest Virtual Infectious Diseases and Immunology Conference
June 08, 2020 07:00 ET | RedHill Biopharma Ltd.
TEL-AVIV, Israel and RALEIGH, N.C., June 08, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that...
Logo-InveniAI.png
InveniAI Announces Strategic Partnership with TB Alliance to Advance the Development of Transformative Therapies for Tuberculosis
June 02, 2020 08:00 ET | InveniAI
GUILDFORD, Conn., June 02, 2020 (GLOBE NEWSWIRE) -- InveniAI® LLC, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across...
Beroni Logo @ Dec 2019.png
Beroni Group Issues US$2.97 million of Convertible Notes to Fund Growth Plans
May 27, 2020 09:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, May 27, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...
Co-Diagnostics (NASDAQ:CODX) Part of Silicon Slopes Initiative Inking “Big Dollar Contracts” for Coronavirus Testing
April 28, 2020 12:25 ET | BDA International
New York City, April 28, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a Utah biotech with a unique, patented molecular diagnostic testing platform, recently announced...
NOVARTIS logo.jpg
Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients
April 20, 2020 01:32 ET | Novartis International AG
Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease Trial...
NOVARTIS logo.jpg
Novartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program
April 02, 2020 17:05 ET | Novartis International AG
New clinical trial to evaluate Jakavi® (ruxolitinib) in patients with COVID-19 associated cytokine storm  Cytokine storm is a type of severe immune overreaction that can result from coronavirus...
Reports and Data.jpeg-01
ELISpot and Fluorospot Assay Market To Reach USD 408.8 Million By 2026 | Reports and Data
March 24, 2020 13:00 ET | Reports and Data
New York, March 24, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the ELISpot and Fluorospot Assay Market was valued at USD 123.5 million in 2018 and is expected to...
HealthEC_logo.jpg
HealthEC’s Dr. Jenifer Leaf Jaeger Cited in HUD Report on Infectious Disease Prevention
March 17, 2020 15:14 ET | HealthEC
EDISON, N.J., March 17, 2020 (GLOBE NEWSWIRE) -- HealthEC, LLC the 2019 Best in KLAS provider of population health management solutions, today announced that Senior Medical Director Jenifer Leaf...
fior-markets-logo.jpg
Global Genetic Testing Services Market is Expected to Reach USD 67.1 Billion by 2025 : Fior Markets
February 25, 2020 20:00 ET | Fior Markets
Newark, NJ, Feb. 25, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global genetic testing services market is expected to grow from USD 34.5 Billion in 2017 to USD 67.1...